Ä¢¹½ÊÓƵ

Team members at the Ä¢¹½ÊÓƵ Epilepsy Center conduct and participate in basic science and clinical research to evaluate new therapies for epilepsy.

Our team is proud to have played a significant role in developing and assessing most of the new anti-seizure medications available today. We continue to conduct clinical trials to develop new, better drugs.

Specialists at Ä¢¹½ÊÓƵ Epilepsy Center have been crucial in developing:

• Vagal nerve stimulation (VNS), which is now an FDA-approved therapy
• Deep brain stimulation, a therapy approved for Parkinson's disease that is under study for epilepsy through the SANTE trial

How Our Research Helps Ä¢¹½ÊÓƵ Patients

Patients whose epilepsy is not responding to standard treatments may participate in a clinical trial testing a new approach. Participation in a clinical trial is voluntary.

Patients enrolled in an investigational study at Ä¢¹½ÊÓƵ Epilepsy Center receive:

• Careful medical supervision by a team of experts
• Trial medication at no cost to the patient
• Free comprehensive care (laboratory tests and studies, EEG and MRI in some cases, and doctors' visits)
• Compensation for travel